Skip to main content

RCUS

Arcus Biosciences, Inc.
Last price
$24.37
As of

Active signals for RCUS

No recent signals on RCUS in the last 180 days.

Top institutional holders of RCUS (13F)

FundMarket value% portfolioQoQ
Point72 Asset Management, L.P.$78.2M0.09%-24.3%
Point72 Asset Management, L.P.$58.9M0.10%,
RENAISSANCE TECHNOLOGIES LLC$9.2M0.01%+1198.8%
TWO SIGMA INVESTMENTS, LP$6.8M0.01%+123.9%
TWO SIGMA INVESTMENTS, LP$6.4M0.01%,
D. E. Shaw & Co., Inc.$5.6M0.00%+203.1%
TWO SIGMA INVESTMENTS, LP$3.3M0.00%-70.4%
RENAISSANCE TECHNOLOGIES LLC$3M0.00%,
Point72 Asset Management, L.P.$2.8M0.00%-96.1%
D. E. Shaw & Co., Inc.$2M0.00%+330.6%
CITADEL ADVISORS LLC$889K0.00%+4.5%
RENAISSANCE TECHNOLOGIES LLC$779K0.00%-85.1%
CITADEL ADVISORS LLC$486K0.00%,
D. E. Shaw & Co., Inc.$270K0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, RCUS

See more RCUS signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track RCUS in your watchlist and get notified the moment a new signal fires.

Track RCUS on Kresmion →